Suzhou Zelgen Biopharmaceuticals Co., Ltd. engages in the innovation, research, development, manufacturing, and commercialization of new medications. Its products include tablets and capsules of small molecule drugs and protein drugs, which are mainly for the treatments of cancer and hematologic diseases. The company was founded by Ze Lin Sheng, Hui Ping Lu, and Su Liu on March 18, 2009 and is headquartered in Kunshan, China.